Global Human Cytomegalovirus (HCMV) 65 kDa Phosphoprotein Market Report (2026–2036)
Market Overview
The global Human Cytomegalovirus (HCMV) 65 kDa Phosphoprotein market is projected to grow steadily from 2026 to 2036, driven by increasing R&D in antiviral therapies, transplant rejection management, and oncology applications. The market is expected to expand at a significant CAGR during the forecast period, supported by advancements in immunotherapy and vaccine development.
Key Players
- Astellas Pharma Inc.
- Hookipa Biotech AG
- Immunomic Therapeutics Inc.
- Vakzine Projekt Management GmbH
- Vaximm AG
- VBI Vaccines Inc.
- Vical Inc.
- Moderna Inc.
- Gilead Sciences Inc.
- Merck & Co., Inc.
- Pfizer Inc.
- Novartis AG
- Johnson & Johnson (Janssen Pharmaceuticals)
- GlaxoSmithKline plc (GSK)
- Sanofi Pasteur
Segments Analysis
By Product Type
- HB-101
- CyMVectin
- ASP-0113
- PepVax
- Others (next-generation recombinant vaccines, peptide-based therapies, DNA/RNA-based immunotherapies)
By Application
- Brain Tumor
- Hematological Tumor
- Kidney Transplant Rejection
- Liver Transplant Rejection
- Others (lung transplant rejection, congenital CMV infection management, immunocompromised patient therapies)
Regional Analysis
- North America (United States, Canada, Mexico)
- Europe (Germany, France, UK, Italy, Spain, Russia, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific)
- Central & South America (Brazil, Argentina, Rest of South America)
- Middle East & Africa (Saudi Arabia, Turkey, Rest of MEA)
Porter’s Five Forces Analysis
- Threat of New Entrants – Moderate, due to high R&D costs and regulatory barriers.
- Bargaining Power of Suppliers – Moderate, as specialized raw materials and biotechnological expertise are required.
- Bargaining Power of Buyers – High, with hospitals, research institutes, and governments demanding cost-effective solutions.
- Threat of Substitutes – Moderate, with alternative antiviral therapies and transplant rejection drugs available.
- Industry Rivalry – High, driven by intense competition among global pharma and biotech firms.
SWOT Analysis
Strengths
- Strong pipeline of vaccines and immunotherapies
- Increasing global awareness of CMV-related complications
- Strategic collaborations and licensing agreements
Weaknesses
- High development costs and long regulatory timelines
- Limited awareness in emerging markets
Opportunities
- Expansion into Asia-Pacific and Latin America
- Rising demand for transplant rejection therapies
- Technological advancements in mRNA and DNA-based vaccines
Threats
- Stringent regulatory approvals
- Competition from established antiviral therapies
- Risk of clinical trial failures
Trend Analysis
- Growing adoption of mRNA-based vaccines for CMV prevention.
- Increasing focus on oncology applications (CMV-related tumors).
- Expansion of personalized immunotherapy approaches.
- Rising collaborations between biotech startups and large pharmaceutical companies.
Drivers & Challenges
Drivers
- Rising incidence of CMV infections in immunocompromised patients.
- Increasing organ transplant procedures worldwide.
- Advances in molecular biology and vaccine technology.
Challenges
- High R&D expenditure and uncertain clinical outcomes.
- Regulatory hurdles across multiple regions.
- Limited awareness and diagnostic infrastructure in developing countries.
Value Chain Analysis
- Upstream: Raw material suppliers (biological reagents, cell lines, genetic materials).
- Midstream: Biotech and pharma companies developing vaccines and therapies.
- Downstream: Hospitals, transplant centers, oncology clinics, research institutes.
- End Users: Patients undergoing transplants, oncology patients, immunocompromised individuals.
Quick Recommendations for Stakeholders
- Manufacturers: Invest in next-generation vaccine platforms (mRNA, DNA-based).
- Investors: Focus on companies with strong clinical pipelines and strategic partnerships.
- Healthcare Providers: Enhance CMV screening protocols for transplant patients.
- Policy Makers: Support awareness campaigns and funding for CMV-related research.
- Distributors: Expand presence in Asia-Pacific and Latin America to capture emerging demand.
Table of Contents
Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Report 2018
1 Human cytomegalovirus 65 kDa Phosphoprotein Market Overview
1.1 Product Overview and Scope of Human cytomegalovirus 65 kDa Phosphoprotein
1.2 Classification of Human cytomegalovirus 65 kDa Phosphoprotein by Product Category
1.2.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Market Size (Sales) Comparison by Type
1.2.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Market Size (Sales) Market Share by Type (Product Category) in
1.2.3 HB-101
1.2.4 CyMVectin
1.2.5 ASP-0113
1.2.6 PepVax
1.2.7 Others
1.3 Global Human cytomegalovirus 65 kDa Phosphoprotein Market by Application/End Users
1.3.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales (Volume) and Market Share Comparison by Application
1.3.1 Brain Tumor
1.3.2 Hemotaological Tumor
1.3.3 Kidney Transplant Rejection
1.3.4 Liver Transplant Rejection
1.3.5 Others
1.4 Global Human cytomegalovirus 65 kDa Phosphoprotein Market by Region
1.4.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Market Size (Value) Comparison by Region
1.4.2 United States Human cytomegalovirus 65 kDa Phosphoprotein Status and Prospect
1.4.3 Europe Human cytomegalovirus 65 kDa Phosphoprotein Status and Prospect
1.4.4 China Human cytomegalovirus 65 kDa Phosphoprotein Status and Prospect
1.4.5 Japan Human cytomegalovirus 65 kDa Phosphoprotein Status and Prospect
1.4.6 Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Status and Prospect
1.4.7 India Human cytomegalovirus 65 kDa Phosphoprotein Status and Prospect
1.5 Global Market Size (Value and Volume) of Human cytomegalovirus 65 kDa Phosphoprotein
1.5.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate
1.5.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue and Growth Rate
2 Global Human cytomegalovirus 65 kDa Phosphoprotein Competition by Players/Suppliers, Type and Application
2.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Market Competition by Players/Suppliers
2.1.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales and Market Share of Key Players/Suppliers ()
2.1.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue and Share by Players/Suppliers ()
2.2 Global Human cytomegalovirus 65 kDa Phosphoprotein (Volume and Value) by Type
2.2.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales and Market Share by Type ()
2.2.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue and Market Share by Type ()
2.3 Global Human cytomegalovirus 65 kDa Phosphoprotein (Volume and Value) by Region
2.3.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales and Market Share by Region ()
2.3.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue and Market Share by Region ()
2.4 Global Human cytomegalovirus 65 kDa Phosphoprotein (Volume) by Application
3 United States Human cytomegalovirus 65 kDa Phosphoprotein (Volume, Value and Sales Price)
3.1 United States Human cytomegalovirus 65 kDa Phosphoprotein Sales and Value ()
3.1.1 United States Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate ()
3.1.2 United States Human cytomegalovirus 65 kDa Phosphoprotein Revenue and Growth Rate ()
3.1.3 United States Human cytomegalovirus 65 kDa Phosphoprotein Sales Price Trend ()
3.2 United States Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume and Market Share by Players ()
3.3 United States Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume and Market Share by Type ()
3.4 United States Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume and Market Share by Application ()
4 Europe Human cytomegalovirus 65 kDa Phosphoprotein (Volume, Value and Sales Price)
4.1 Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales and Value ()
4.1.1 Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate ()
4.1.2 Europe Human cytomegalovirus 65 kDa Phosphoprotein Revenue and Growth Rate ()
4.1.3 Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales Price Trend ()
4.2 Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume and Market Share by Players ()
4.3 Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume and Market Share by Type ()
4.4 Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume and Market Share by Application ()
5 China Human cytomegalovirus 65 kDa Phosphoprotein (Volume, Value and Sales Price)
5.1 China Human cytomegalovirus 65 kDa Phosphoprotein Sales and Value ()
5.1.1 China Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate ()
5.1.2 China Human cytomegalovirus 65 kDa Phosphoprotein Revenue and Growth Rate ()
5.1.3 China Human cytomegalovirus 65 kDa Phosphoprotein Sales Price Trend ()
5.2 China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume and Market Share by Players ()
5.3 China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume and Market Share by Type ()
5.4 China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume and Market Share by Application ()
6 Japan Human cytomegalovirus 65 kDa Phosphoprotein (Volume, Value and Sales Price)
6.1 Japan Human cytomegalovirus 65 kDa Phosphoprotein Sales and Value ()
6.1.1 Japan Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate ()
6.1.2 Japan Human cytomegalovirus 65 kDa Phosphoprotein Revenue and Growth Rate ()
6.1.3 Japan Human cytomegalovirus 65 kDa Phosphoprotein Sales Price Trend ()
6.2 Japan Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume and Market Share by Players ()
6.3 Japan Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume and Market Share by Type ()
6.4 Japan Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume and Market Share by Application ()
7 Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein (Volume, Value and Sales Price)
7.1 Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Sales and Value ()
7.1.1 Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate ()
7.1.2 Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Revenue and Growth Rate ()
7.1.3 Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Sales Price Trend ()
7.2 Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume and Market Share by Players ()
7.3 Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume and Market Share by Type ()
7.4 Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume and Market Share by Application ()
8 India Human cytomegalovirus 65 kDa Phosphoprotein (Volume, Value and Sales Price)
8.1 India Human cytomegalovirus 65 kDa Phosphoprotein Sales and Value ()
8.1.1 India Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate ()
8.1.2 India Human cytomegalovirus 65 kDa Phosphoprotein Revenue and Growth Rate ()
8.1.3 India Human cytomegalovirus 65 kDa Phosphoprotein Sales Price Trend ()
8.2 India Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume and Market Share by Players ()
8.3 India Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume and Market Share by Type ()
8.4 India Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume and Market Share by Application ()
9 Global Human cytomegalovirus 65 kDa Phosphoprotein Players/Suppliers Profiles and Sales Data
9.1 Astellas Pharma Inc
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Human cytomegalovirus 65 kDa Phosphoprotein Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales, Revenue, Price and Gross Margin ()
9.1.4 Main Business/Business Overview
9.2 Hookipa Biotech AG
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Human cytomegalovirus 65 kDa Phosphoprotein Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Sales, Revenue, Price and Gross Margin ()
9.2.4 Main Business/Business Overview
9.3 Immunomic Therapeutics Inc
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Human cytomegalovirus 65 kDa Phosphoprotein Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales, Revenue, Price and Gross Margin ()
9.3.4 Main Business/Business Overview
9.4 Vakzine Projekt Management GmbH
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Human cytomegalovirus 65 kDa Phosphoprotein Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Sales, Revenue, Price and Gross Margin ()
9.4.4 Main Business/Business Overview
9.5 Vaximm AG
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Human cytomegalovirus 65 kDa Phosphoprotein Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Sales, Revenue, Price and Gross Margin ()
9.5.4 Main Business/Business Overview
9.6 VBI Vaccines Inc
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Human cytomegalovirus 65 kDa Phosphoprotein Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales, Revenue, Price and Gross Margin ()
9.6.4 Main Business/Business Overview
9.7 Vical Inc
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Human cytomegalovirus 65 kDa Phosphoprotein Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Vical Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales, Revenue, Price and Gross Margin ()
9.7.4 Main Business/Business Overview
...
10 Human cytomegalovirus 65 kDa Phosphoprotein Maufacturing Cost Analysis
10.1 Human cytomegalovirus 65 kDa Phosphoprotein Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Human cytomegalovirus 65 kDa Phosphoprotein
10.3 Manufacturing Process Analysis of Human cytomegalovirus 65 kDa Phosphoprotein
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Human cytomegalovirus 65 kDa Phosphoprotein Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Human cytomegalovirus 65 kDa Phosphoprotein Major Manufacturers in
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Human cytomegalovirus 65 kDa Phosphoprotein Market Forecast (2018-2025)
14.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Human cytomegalovirus 65 kDa Phosphoprotein Price and Trend Forecast (2018-2025)
14.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Forecast by Type (2018-2025)
14.3.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Forecast by Type (2018-2025)
14.3.3 Global Human cytomegalovirus 65 kDa Phosphoprotein Price Forecast by Type (2018-2025)
14.4 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Forecast by Application (2018-2025)
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Human cytomegalovirus 65 kDa Phosphoprotein
Figure Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Comparison (K Pcs) by Type
Figure Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Type (Product Category) in
Figure HB-101 Product Picture
Figure CyMVectin Product Picture
Figure ASP-0113 Product Picture
Figure PepVax Product Picture
Figure Others Product Picture
Figure Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Comparison (K Pcs) by Application
Figure Global Sales Market Share of Human cytomegalovirus 65 kDa Phosphoprotein by Application in
Figure Brain Tumor Examples
Table Key Downstream Customer in Brain Tumor
Figure Hemotaological Tumor Examples
Table Key Downstream Customer in Hemotaological Tumor
Figure Kidney Transplant Rejection Examples
Table Key Downstream Customer in Kidney Transplant Rejection
Figure Liver Transplant Rejection Examples
Table Key Downstream Customer in Liver Transplant Rejection
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Human cytomegalovirus 65 kDa Phosphoprotein Market Size (Million USD) by Regions
Figure United States Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Million USD) and Growth Rate
Figure Europe Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Million USD) and Growth Rate
Figure China Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Million USD) and Growth Rate
Figure Japan Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Million USD) and Growth Rate
Figure Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Million USD) and Growth Rate
Figure India Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Million USD) and Growth Rate
Figure Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume (K Pcs) and Growth Rate
Figure Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Million USD) and Growth Rate
Figure Global Market Major Players Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume (K Pcs) ()
Table Global Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) of Key Players/Suppliers ()
Table Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Share by Players/Suppliers ()
Figure Human cytomegalovirus 65 kDa Phosphoprotein Sales Share by Players/Suppliers
Figure Human cytomegalovirus 65 kDa Phosphoprotein Sales Share by Players/Suppliers
Figure Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Million USD) by Players/Suppliers ()
Table Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Million USD) by Players/Suppliers ()
Table Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Share by Players/Suppliers ()
Table Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Share by Players
Table Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Share by Players
Table Global Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) and Market Share by Type ()
Table Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Share (K Pcs) by Type ()
Figure Sales Market Share of Human cytomegalovirus 65 kDa Phosphoprotein by Type ()
Figure Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate by Type ()
Table Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Million USD) and Market Share by Type ()
Table Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Share by Type ()
Figure Revenue Market Share of Human cytomegalovirus 65 kDa Phosphoprotein by Type ()
Figure Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate by Type ()
Table Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume (K Pcs) and Market Share by Region ()
Table Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Share by Region ()
Figure Sales Market Share of Human cytomegalovirus 65 kDa Phosphoprotein by Region ()
Figure Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate by Region in
Table Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Million USD) and Market Share by Region ()
Table Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Share (%) by Region ()
Figure Revenue Market Share of Human cytomegalovirus 65 kDa Phosphoprotein by Region ()
Figure Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate by Region in
Table Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Million USD) and Market Share by Region ()
Table Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Share (%) by Region ()
Figure Revenue Market Share of Human cytomegalovirus 65 kDa Phosphoprotein by Region ()
Figure Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Region in
Table Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume (K Pcs) and Market Share by Application ()
Table Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Share (%) by Application ()
Figure Sales Market Share of Human cytomegalovirus 65 kDa Phosphoprotein by Application ()
Figure Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Application ()
Figure United States Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) and Growth Rate ()
Figure United States Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Million USD) and Growth Rate ()
Figure United States Human cytomegalovirus 65 kDa Phosphoprotein Sales Price (USD/Pcs) Trend ()
Table United States Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume (K Pcs) by Players ()
Table United States Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Players ()
Figure United States Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Players in
Table United States Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume (K Pcs) by Type ()
Table United States Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Type ()
Figure United States Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Type in
Table United States Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume (K Pcs) by Application ()
Table United States Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Application ()
Figure United States Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Application in
Figure Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) and Growth Rate ()
Figure Europe Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Million USD) and Growth Rate ()
Figure Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales Price (USD/Pcs) Trend ()
Table Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume (K Pcs) by Players ()
Table Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Players ()
Figure Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Players in
Table Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume (K Pcs) by Type ()
Table Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Type ()
Figure Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Type in
Table Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume (K Pcs) by Application ()
Table Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Application ()
Figure Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Application in
Figure China Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) and Growth Rate ()
Figure China Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Million USD) and Growth Rate ()
Figure China Human cytomegalovirus 65 kDa Phosphoprotein Sales Price (USD/Pcs) Trend ()
Table China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume (K Pcs) by Players ()
Table China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Players ()
Figure China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Players in
Table China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume (K Pcs) by Type ()
Table China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Type ()
Figure China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Type in
Table China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume (K Pcs) by Application ()
Table China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Application ()
Figure China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Application in
Figure Japan Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) and Growth Rate ()
Figure Japan Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Million USD) and Growth Rate ()
Figure Japan Human cytomegalovirus 65 kDa Phosphoprotein Sales Price (USD/Pcs) Trend ()
Table Japan Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume (K Pcs) by Players ()
Table Japan Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Players ()
Figure Japan Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Players in
Table Japan Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume (K Pcs) by Type ()
Table Japan Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Type ()
Figure Japan Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Type in
Table Japan Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume (K Pcs) by Application ()
Table Japan Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Application ()
Figure Japan Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Application in
Figure Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) and Growth Rate ()
Figure Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Million USD) and Growth Rate ()
Figure Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Sales Price (USD/Pcs) Trend ()
Table Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume (K Pcs) by Players ()
Table Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Players ()
Figure Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Players in
Table Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume (K Pcs) by Type ()
Table Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Type ()
Figure Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Type in
Table Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume (K Pcs) by Application ()
Table Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Application ()
Figure Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Application in
Figure India Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) and Growth Rate ()
Figure India Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Million USD) and Growth Rate ()
Figure India Human cytomegalovirus 65 kDa Phosphoprotein Sales Price (USD/Pcs) Trend ()
Table India Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume (K Pcs) by Players ()
Table India Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Players ()
Figure India Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Players in
Table India Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume (K Pcs) by Type ()
Table India Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Type ()
Figure India Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Type in
Table India Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume (K Pcs) by Application ()
Table India Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Application ()
Figure India Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Application in
Table Astellas Pharma Inc Basic Information List
Table Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin ()
Figure Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate ()
Figure Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales Global Market Share ()
Figure Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Revenue Global Market Share ()
Table Hookipa Biotech AG Basic Information List
Table Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin ()
Figure Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate ()
Figure Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Sales Global Market Share ()
Figure Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Revenue Global Market Share ()
Table Immunomic Therapeutics Inc Basic Information List
Table Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin ()
Figure Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate ()
Figure Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales Global Market Share (
Figure Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Revenue Global Market Share ()
Table Vakzine Projekt Management GmbH Basic Information List
Table Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin ()
Figure Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate ()
Figure Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Sales Global Market Share ()
Figure Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Revenue Global Market Share ()
Table Vaximm AG Basic Information List
Table Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin ()
Figure Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate ()
Figure Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Sales Global Market Share ()
Figure Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Revenue Global Market Share ()
Table VBI Vaccines Inc Basic Information List
Table VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin ()
Figure VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate ()
Figure VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales Global Market Share (
Figure VBI Vaccines Inc
Key Players
- Astellas Pharma Inc.
- Hookipa Biotech AG
- Immunomic Therapeutics Inc.
- Vakzine Projekt Management GmbH
- Vaximm AG
- VBI Vaccines Inc.
- Vical Inc.
- Moderna Inc.
- Gilead Sciences Inc.
- Merck & Co., Inc.
- Pfizer Inc.
- Novartis AG
- Johnson & Johnson (Janssen Pharmaceuticals)
- GlaxoSmithKline plc (GSK)
- Sanofi Pasteur
Segments Analysis
By Product Type
- HB-101
- CyMVectin
- ASP-0113
- PepVax
- Others (next-generation recombinant vaccines, peptide-based therapies, DNA/RNA-based immunotherapies)
By Application
- Brain Tumor
- Hematological Tumor
- Kidney Transplant Rejection
- Liver Transplant Rejection
- Others (lung transplant rejection, congenital CMV infection management, immunocompromised patient therapies)
Regional Analysis
- North America (United States, Canada, Mexico)
- Europe (Germany, France, UK, Italy, Spain, Russia, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific)
- Central & South America (Brazil, Argentina, Rest of South America)
- Middle East & Africa (Saudi Arabia, Turkey, Rest of MEA)
